Cargando…
Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
SIMPLE SUMMARY: Drug resistance is the key factor contributing to the therapeutic failure of lung cancer and the deaths related to lung cancer. Our study demonstrated that small molecular weight non-psychotropic phytochemical, cannabidiol (CBD), inhibits growth and metastasis of drug-resistant non-s...
Autores principales: | Misri, Swati, Kaul, Kirti, Mishra, Sanjay, Charan, Manish, Verma, Ajeet Kumar, Barr, Martin P., Ahirwar, Dinesh K., Ganju, Ramesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909073/ https://www.ncbi.nlm.nih.gov/pubmed/35267489 http://dx.doi.org/10.3390/cancers14051181 |
Ejemplares similares
-
Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer
por: Charan, Manish, et al.
Publicado: (2020) -
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
por: Charan, Manish, et al.
Publicado: (2020) -
Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages
por: Ahirwar, Dinesh K., et al.
Publicado: (2023) -
Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer
por: Mishra, Sanjay, et al.
Publicado: (2021) -
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment
por: Mishra, Sanjay, et al.
Publicado: (2022)